Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3)
US11753472B2 · kind B2 · utility
1Cited by
21References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 27, 2021 |
| Grant date | Sep 12, 2023 |
| Priority date | — |
| Expiry date | Oct 27, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are anti-T Cell Immunoglobulin and Mucin Protein-3 (TIM 3) antibodies having particular immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide sequences and methods of using the anti-TIM-3 antibodies to treat a disorder or disease that is responsive to TIM-3 inhibition, such as cancer, an infectious disease, or an autoimmune disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.